Cynthia Schwalm

Companies

• Caladrius BiosciencesBoard member Nov 8, 2018 to now¹
• G1 Therapeutics, Inc.Board member Jun 11, 2018 to Sep 18, 2024²
• Kadmon Holdings, Inc.Board member Jan 23, 2019 to Nov 9, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CBCaladrius Biosciences LSTA95,446 shares⁴$93.5K at $0.98Jan 9, 2026
• KKadmon Holdings, Inc.0 shares⁵Nov 9, 2021
• GTG1 Therapeutics, Inc.0 shares⁶Sep 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 9, 2026Granted 30,456 shares of Caladrius Biosciences⁴
• Jan 9, 2025Granted 15,789 shares of Caladrius Biosciences⁷
• Sep 18, 2024U 15,889 shares of G1 Therapeutics, Inc.⁶
• Sep 18, 2024Returned to company 20,000 shares of G1 Therapeutics, Inc.⁶
• Jun 13, 2024Granted 10,000 shares of G1 Therapeutics, Inc.⁸
• Jan 9, 2024Granted 19,480 shares of Caladrius Biosciences⁹
• Jun 15, 2023Granted 10,000 shares of G1 Therapeutics, Inc.¹⁰
• Jan 9, 2023Granted 20,000 shares of Caladrius Biosciences¹¹
• Jun 23, 2022Granted 10,000 shares of G1 Therapeutics, Inc.¹²
• Jan 10, 2022Granted 65,430 shares of Caladrius Biosciences¹³
• Nov 9, 2021Returned to company 10,850 shares at $9.50 of Kadmon Holdings, Inc.⁵
• Nov 8, 2021Gift 20,150 shares of Kadmon Holdings, Inc.⁵